BSECompany Update4d ago · 4 Nov 2026, 08:38 pm

Reappointment of Mr. M. R. Kumar as Independent Director of the Company for second term with effect from April 1, 2027.

Aurobindo Pharma Ltd · 524804

✦ AI SummaryMgmt Change

Aurobindo Pharma Ltd has announced the reappointment of Mr. M. R. Kumar as Independent Director for a second term of five years, effective April 1, 2027.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Change in Directorate

Attachments (1)

📄

19f7f04b-8f38-4330-82c9-08c2f7f25166.pdf

pdf

Download →
View document text
November 4, 2026 To To Listing Department, The Corporate Relations Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED Exchange Plaza, Bandra Kurla Complex, Bandra (E), Phiroz Jeejeebhoy Towers, 25th floor, Dalal Street, MUMBAI -400 051 MUMBAI -400 001 Company Code No. AUROPHARMA Company Code No. 524804 Dear Sir / Madam, Sub: Re-appointment of a Director The Board of Directors of the Company at its meeting held today, November 4, 2026, has, based on the recommendation of the Nomination and Remuneration Committee and subject to the approval of the members through postal ballot, approved the re-appointment of Mr. Mangalam Ramasubramanian Kumar (DIN 03628755) as Non-executive and Independent Director of the Company for the second term of five years with effect from April 1, 2027. His first term as Non-executive and Independent Director is completing on March 31, 2027. He is not related to any Director / Key Managerial Personnel of the Company. We hereby affirm that Mr. Mangalam Ramasubramanian Kumar is not debarred from holding the office of Director by virtue of any SEBI order or any such authority. The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, in this regard is attached as Annexure. The Board meeting commenced at 4:15 p.m. and concluded at 6:00 p.m. Please take the information on record. Yours faithfully, For AUROBINDO PHARMA LIMITED B. Adi Reddy Company Secretary Encl: as above Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038, Telangana, India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com Annexure Information as required under Regulation 30 - Part A of Para A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Sl. Particulars Description 1 Name Mr. Mangalam Ramasubramanian Kumar (DIN 03628755) 2 Reason for Change Re-appointment as a Non-executive and Independent Director of the Company for the second term of five years with effect from April 1, 2027 as his first term is completing on March 31, 2027. 3 Date of appointment/ re- April 1, 2027 appointment / cessation (as applicable) & term of Re-appointment as a Non-executive and Independent Director of the appointment/ re- Company for the second term of five years with effect from April 1, 2027, appointment not to liable to retire by rotation, subject to approval of members by way of special resolution. He will be entitled to receive sitting fees for attending the board and committee meetings of the Company and commission. 4 Brief Profile (in case of Mr. Mangalam Ramasubramanian Kumar is a Science graduate from appointment of a University of Madras. He served as Chairman, LIC of India from March director) 2019 to March 2023. He joined LIC of India in 1983 as a Direct Recruit Officer. In a career spanning more than three and a half decades, he has had the unique privilege of heading three Zones of LIC of India, viz. Southern Zone, North Central Zone and Northern Zone, head quartered at Chennai, Kanpur and Delhi, respectively. As an Executive Director, he headed the Personnel Department as well as the Pension and Group Insurance vertical of the Corporation. During his tenure, several initiatives were rolled out for the benefit of the employees. Moreover, working in different streams of life insurance management viz., administrative, marketing, group and social securities, has given him the twin advantages of enriched knowledge and clarity on processes and procedures in the life insurance industry. Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038, Telangana, India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com In addition to being Chairman of LIC, he was also the Non-Executive Chairman of LIC Housing Finance Ltd., LIC Pension Fund Ltd, LIC Mutual Fund AMC Ltd., LIC Cards Services Ltd., IDBI Bank, LIC Singapore Pte. Ltd., LIC Lanka Ltd., LIC (International) BSC, Bahrain, LIC Nepal. Ltd. As Non-Executive Chairman of IDBI Bank, he was involved in strategizing the turnaround of IDBI Bank from a loss making entity to profitable one. He also held position as Director on the Board of Kenindia Assurance Co. Ltd, Kenya and ACC Ltd., India. He was also Chairman of the Governing Board of National Insurance Academy, President of Insurance Institute of India and Chairman of Council of Insurance Ombudsman. Currently, he is Director on the Board of Cholamandalam Investment and Finance Company Limited, Aurobindo Pharma Usa Inc., and Non- executive Chairman of Bank of India. 5 Disclosure of He is not related to any Director / Key Managerial Personnel of the relationships between Company directors (in case of appointment of director) Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038, Telangana, India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com